Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Visit One News Page for Italy news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Italy news headlines.

older | 1 | .... | 1028 | 1029 | (Page 1030) | 1031 | 1032 | .... | 1077 | newer

    0 0

    Biosurfactants Market By Products, By Application, Regional Outlook (U.S., Germany, UK, France, Italy, China, India, Japan, Thailand, Brazil), Application Potential, Price Trend, Competitive Market Share & Forecast, 2018 – 2024

    Sellbyville, Delaware, Oct. 03, 2018 (GLOBE NEWSWIRE) --Global Biosurfactants Market is expected to cross USD 2.7 billion by 2024; according to a new research report by Global Market Insights, Inc. Increasing consumer consciousness towards usage of eco-friendly products in cosmetic & personal care industry may drive biosurfactants market demand. Growing usage of these products in anti-ageing creams and lotions owing to its anti-microbial properties may spur market demand. Supportive and flexible regulations pertaining to commercial scale production of biosurfactants will benefit industry participants in short as well as long- term.

    Biosurfactants are amphiphilic compounds which are produced in living spaces or excreted through extracellular hydrophobic moieties. It is used to stabilize aerated systems, control agglomeration of fat globules and improve shelf life and texture of starch containing products and fat-based products in food processing industries. Rising ecological concerns about the use of synthetic surfactants including low degradability, low toxicity is likely to be key aspects to drive biosurfactants market demand.

    *Request for a sample of this research report @ *https://www.gminsights.com/request-sample/detail/484

    APG (Alkyl polyglucosides) biosurfactants market size may surpass consumption at over 140 kilo tons by 2024. APG are widely used in hand dishwash detergents, hard surface cleaners, bathroom cleaners, bottle washing, grill cleaners and window cleaners owing to its water-soluble properties and are compatible with anionic, cationic and other non-ionic surfactants. APG from agricultural chemicals application may register gains close to 3.5% at the end of projected timeframe it acts as agricultural adjuvant and contributes substantially to safer and most effective when applied to herbicides, which in turn foster biosurfactants industry growth.

    Sorbitan ester biosurfactants market demand may exceed USD 95 million by 2024. These are used as emulsifying agent for the preparation of ointments, creams, cosmetics and emulsions owing to their advance properties which include higher compatibility and enhanced stability with materials. These are extensively used in personal care application as they act as water-oil emulsifier for protective, baby care products and general-purpose soothing creams. These are used as wetting and dispersing agent for sunscreens and decorative cosmetics, thus stimulating biosurfactants demand.

    Browse key industry insights spread across 530 pages with 934 market data tables and 37 figures & charts from the report, *“Biosurfactants Market”* in detail along with the table of contents:

    https://www.gminsights.com/industry-analysis/biosurfactants-market-report

    Sucrose ester market size was estimated at over USD 25 million in 2017. The product has multifunctional physical abilities which will help to increase in health concerns among calorie-conscious population. They possess the property of emulsification and act as a replacement of fats. Sucrose ester are broadly used in food processing application and may register growth at over 3.5% by 2024 due to its high-quality and effective food emulsifier and surfactant which caters to multiple functions including dispersion and emulsification averting retrogradation of starch and controls crystallization. These products are mainly used in sugar, fruit, food & vegetable preservation, thereby driving the biosurfactants demand.

    U.S. market demand may witness growth at about 4% over the forecast period. Growing consumer awareness regarding the risk associated with synthetic surfactant used in household detergents will stimulate the demand for natural substitutes of synthetic surfactant in laundry detergents, which may favor industry growth in the region.

    Germany market growth is anticipated to surpass USD 375 million by 2024 owing to increasing consumer concerns towards environmentally friendly products coupled with supportive government regulations with rising health consciousness which is likely to drive the regional growth.

    China biosurfactants market size may register significant growth at around 4.5% over the predicted timeframe. China and India have extensive existence of textile industries which may increase the usage of the product. Growth in the number of middle-class family, disposable income, and their constancy to purchase personal care and consumer products are also the major drivers to boost the regional product demand.

    Soliance, Sun Products, Croda, TeeGene and AGAE Technologies are the key industrial players in biosurfactants market. New product development and strong R&D may boost the product portfolio, which in turn foster the industry growth. Most of the manufacturers are focusing to develop novel products to increase biosurfactants demand which in turn may accelerate the product market over the forecast timeframe.

    *Make an inquiry for purchasing this report @* https://www.gminsights.com/inquiry-before-buying/484

    *Browse Related Reports:*

    · *Biopesticides Market Size 2017 – 2024*

    Global Biopesticides Market revenue was worth over USD 1.8 billion in 2016 and is foreseen to surpass 230 kilo tons by 2024. Rise in crop loss due to insects and diseases, change in farming techniques along with development of pest resistance for several chemicals will fuel global growth.
    https://www.gminsights.com/industry-analysis/biopesticides-market

    · *Biofertilizers Market Size 2016 – 2024*

    Global Biofertilizers Market revenue was worth over USD 1.5 billion in 2016 and will exceed 1,200 kilo tons by 2024. Increasing awareness pertaining to environmental concerns and health hazards from chemical fertilizers on crops & vegetation will propel the global market growth.
    https://www.gminsights.com/industry-analysis/biofertilizers-market

    *About Global Market Insights*

    Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

    CONTACT: Contact Us:
    Arun Hegde
    Corporate Sales, USA
    Global Market Insights, Inc.
    Phone: 1-302-846-7766
    Toll Free: 1-888-689-0688
    Email: sales@gminsights.com
    Web: https://www.gminsights.com
    Blog: http://allchemresearch.com/ Reported by GlobeNewswire 6 minutes ago.

    0 0

    The Italian Finance Minister Tria calls for economic stimulus to reduce the national debt levels.

    *Key Points (via Reuters):*

    The country needs economic stimulus to bring down debt levels

    Increase productivity will bring about economic revival.

    Gov't wants to ensure ongoing debt reduction.

    Will bring this about in line with EU directive.

    Govt to back investment plans by state-controlled companies. Reported by FXstreet.com 2 hours ago.

    0 0

    Companion Animal Diagnostic Market By Technology, By Animal Type, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Poland, China, Japan, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

    Sellbyville, Delaware, Oct. 03, 2018 (GLOBE NEWSWIRE) --Global Companion Animal Diagnostics Market is poised to cross USD 3.2 billion by 2024; according to a new research study published by Global Market Insights, Inc. Local government bodies and animal health workers are involved in setting up strategies to manage interactions between human, animal and environmental health issues. Growing government initiatives such as campaigns undertaken by various organizations and domestic government to encourage growth of animal sector will favor animal diagnostics market growth.

    Reduction in meat prices with delivery of sufficient nutrients by animal food has stimulated the demand for animal products including meat and animal protein.  Moreover, dog and cat meat are being considered as the desired food in majority of Asian countries due to its nutritional value and taste. Increase in demand for companion animal products in developing countries of Asia Pacific region will spur the business growth in forthcoming years.

    *Request for a sample of this research report @ *https://www.gminsights.com/request-sample/detail/2927

    Low out of pocket expenditure on companion animals’ healthcare will be one of the major market impeding factor. Low out of pocket expenditure have severe consequences on healthcare admittance and consumption leading to decline in demand for diagnostic products, hampering the growth of companion animal diagnostic market.

    Immunodiagnostic companion animal diagnostics market accounted for USD 428.5 million in the year 2017.  The immunodiagnostic tests have been used frequently in diagnosis of various diseases such as Echinococcus multilocularis, Taenia solium and Wuchereria bancrofti. Frequent introduction of new diagnostic tests in the market along with rising spending on pet care will drive immunodiagnostic segment growth in the forthcoming years.

    Browse key industry insights spread across 140 pages with 135 market data tables & 10 figures & charts from the report, *“Companion Animal Diagnostics Market”* in detail along with the table of contents:

    https://www.gminsights.com/industry-analysis/companion-animal-diagnostic-market

    Hematology companion animal diagnostic market will witness robust growth at a CAGR of 8.0% during the forecast timeframe. Several hematology techniques are used to access and diagnose common hematological disturbances in veterinary animals. Hematology consists of complete blood count (CBC), one of the most common blood test performed on pets. CBC gives results for hydration status, clotting ability of blood, anemia infection and ability of immune system to respond will stimulate demand, thereby fueling industry growth.

    Dog diagnostic market was valued over USD 722.7 million in the year 2017. Growing trend of pet adoption and humanization, increasing urbanization and rising affluence in emerging economies propels industry growth. Furthermore, increasing research and development for quicker launch of first-in-line drugs thus contributing to significant growth in animal diagnostics market.

     Cat diagnostic market will show considerable amount of growth at a CAGR of 7.9% during the projection period. The population of traditional companion animals, especially cats, has increased due to the willingness of owners to care more for their animals’ health and ability of veterinarians to cure diseases are major aspects fueling animal diagnostics market growth.

    France dominated the European companion animal diagnostic market in the year 2017 and was valued over USD 92.7 million. France accounts for high adoption of pet population, thereby stimulating demand for companion animal diagnostics to control prevalence of zoonotic diseases. According to IFAH Europe, every one out of two houses in France has at least one companion animal. Continuous innovation and frequent introduction of new biologics positively impacts market growth.

    China market is estimated to grow at substantial rate at 11.1% over the forecast timeframe. Escalating demand for animal products in China along with high demand for animal source food drives China’s companion animal diagnostics market. Growing trend of adopting pet further fuels the demand for animal diagnosis. According to the World Veterinary Association report 2015, in China pet ownership is growing fast thus it is anticipated to boost companion animal diagnostics market growth.

    Some of the leading players in the companion animal diagnostics market Abaxis, Heska Corporation, Randox, Virbac, Qiagen, IDEXX Laboratories, Thermo Fisher Scientific, Neogen, Zoetis. These companies focus on strategic decisions to increase the research and development investment in order manufacture superior quality medicines. Merger and acquisitions have also increased the capabilities of the companies and increased their efficiency to sustain in the market by providing better diagnostic solutions.

    *Make an inquiry for purchasing this report @* https://www.gminsights.com/inquiry-before-buying/2927

    *Browse Related Reports:*

    · *Animal Diagnostics Market Size 2017 – 2024*

    Animal Diagnostics Market was valued at over USD 2.8 billion in 2016 and is expected to witness more than 8.0% CAGR from 2017 to 2024. Growing trend of pet adoption along with rising prevalence of zoonotic diseases will drive the market over the forecast time-frame.
    https://www.gminsights.com/industry-analysis/animal-diagnostics-market

    · *Animal Healthcare Market Size 2018 – 2024*

    Animal Healthcare Market outlook valued at above USD 27 billion in 2017 and is projected to grow with a CAGR of nearly 4% during the forecast period, driven by rapidly increasing pet adoption need to control spreading of zoonotic diseases and favorable government initiatives to promote animal healthcare practices.
    https://www.gminsights.com/industry-analysis/animal-healthcare-market

    *About Global Market Insights*

    Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

    CONTACT: Contact Us:
    Arun Hegde
    Corporate Sales, USA
    Global Market Insights, Inc.
    Phone: 1-302-846-7766
    Toll Free: 1-888-689-0688
    Email: sales@gminsights.com
    Web: https://www.gminsights.com
    Blog: http://exsoft.org/category/health/ Reported by GlobeNewswire 2 hours ago.

    0 0

    *More comments* flowing in from the Italian Finance Minister Tria, as he now speaks on the growth slowdown.

    Italy growth slowdown reflects Europe lower growth.

    Gov't strategy takes into account global growth slowdown. Reported by FXstreet.com 2 hours ago.

    0 0

    Reported by SeekingAlpha 2 hours ago.

    0 0

    We found the smile we had lost - Verratti praises PSG boss Tuchel The Italy international midfielder has praised the way that the coach has rapidly integrated with the squad and says the whole team like him Reported by Goal.com 2 hours ago.

    0 0

    Italy's populist government may cut its budget deficit targets from 2020 after investors sold off Italian assets and European Union ministers blasted its plans to jack up spending next year, a government source said on Wednesday. Reported by Reuters India 2 hours ago.

    0 0

    Edmund through to China Open quarter-finals British number one Kyle Edmund is through to the China Open quarter-finals after beating Italy's Matteo Berrettini in three sets. Reported by BBC Sport 2 hours ago.

    0 0

    China Open: Kyle Edmund through to quarter-finals with hard-fought win British number one Kyle Edmund is through to the China Open quarter-finals after beating Italy's Matteo Berrettini in three sets. Reported by BBC Sport 2 hours ago.

    0 0

    Italy currently does not have a law against homophobia and transphobia. Reported by PinkNews 1 hour ago.

    0 0

    Senior Analyst at Danske Bank Piet Christiansen gives his views on the recent developments around the EUR and Italy.

    *Key Quotes*

    “*EUR/USD* remains under pressure after Italy’s budget committee head Borghi yesterday reminded markets that some Italian politicians continue to flirt with the easy way out of debt problems: an Italian exit from the euro”.

    “While this was later decisively dismissed as current government policy, it was certainly a reminder of the ultimate risk to Italy’s fiscal experiment. We expect a further widening of the political risk premium on EUR near term”.

    “USD was little moved by Powell’s gradual hiking comments yesterday but supported by the NAFTA deal. More Fed speakers including Powell are scheduled today”. Reported by FXstreet.com 1 hour ago.

    0 0

    Now's the time to buy Italian bonds, says this $2.4 trillion wealth manager **

    · *UBS Wealth Management says that the recent Italian budget presents a buying opportunity for investors.*
    · *Fears of what the crisis could lead to have led to surging Italian bond yields and falling prices.*
    · *CIO Mark Haefele said on Wednesday that the firm is investing in short term Italian government debt.*
    · *UBS, however, warned to stay away from any Italian debt with a maturity of more than two years.*

    Amid the market panic surrounding Italy over the last week, the chief investment officer of UBS Wealth Management says now's the time to buy. 

    It's a contrarian call: "We are opening an overweight position in two-year Italian government bonds versus cash," Mark Haefele, who works at the $2.4 trillion wealth management arm of the Swiss banking giant, said on Wednesday. "The recent sell-off presents investors with an attractive opportunity." 

    Fears had been mounting in Italy over the brewing budget crisis, which could set the country and its leadership on a collision course with the European Union over excessive spending. Bond yields soared -- the country's benchmark 10-year bond is near its highest level since 2014.

    Rising yields correspond with falling prices for bonds, and according to one of the world's most prominent wealth management firms, those falling prices represent a opportunistic way in. 

    Here's Haefele's reasoning:  

    "While we believe that Italy's credit rating is likely to be downgraded by one notch, the country is likely to retain an investment grade rating for at least the next 12 months, and we believe there is only a very low probability that Italy will default within the next two years. Just 13% of the government's bonds need to be rolled over by the end of 2019, so higher yields only gradually increase the cost of debt."

    Still, Haefele urges caution. He warns against investing in longer-dated Italian debt, while saying investors should not concentrate their portfolios on Italian bonds.

    "There are risks associated with the position," he said. "Italian yields could be pushed higher by escalating tensions between Italy and the European Commission, a breakdown of the current Italian coalition, or the departure of Finance Minister Giovanni Tria."

    *SEE ALSO: Everything you need to know about Italy's budget crisis — which threatens to trigger a major market meltdown*

    Join the conversation about this story »

    NOW WATCH: Ray Dalio says the economy looks like 1937 and a downturn is coming in about two years Reported by Business Insider 1 hour ago.

    0 0

    Is Italy the new Greece? These 6 charts explain why Italy is rattling markets Investors today are breathing a sigh of relief after Italy reportedly bowed to European Union pressure and lowered its budget target. *

    What's going on? 

    *To say it's been a tumultuous few days in the eurozone's third largest economy would be somewhat of an understatement.*
    *

    It all started last week, when Italy submitted its spending plans to the EU. The budget came as a shock: the country said it planned to spend a whopping 2.4% more than it makes over the next three years.

    This target risked breaching EU rules. Investors balked, sending the country's bonds higher and the euro tumbling.

    At one point, the crisis was so acute that some were starting to suggest that Italy could be the next Greece.

    "We have to do everything to avoid a new Greece — this time an Italy — crisis," was the damning assessment of European Commission President Jean-Claude Juncker earlier this week.

    After some bumpy back and forth, the country is reportedly backing off and cutting its budget deficit target for 2021 to 2%. 

    Markets have seen this before, government turmoil has jolted the country twice before in just over two years.

    *These charts show what a long, strange trip it's been. *

    *SEE ALSO: Everything you need to know about Italy's budget crisis — which threatens to trigger a major market meltdown*

    -A high, and rising, budget deficit-

    Italy has run a budget deficit consistently over the past 20 years, and although it has shrunk since the financial crisis, it remains at more than 2% of GDP. 

    The country's new populist government wants to substantially increase the country's spending on infrastructure projects and social welfare programs. There was pushback from Italy's finance minister, but the populists won the day, at least at first. 

    Italy's 2.4% number was higher than expected, and its spending risked falling foul of the European Union's rules on spending and borrowing. Worth noting: any punishment from Brussels would likely stoke further anti-EU sentiment from both of the Eurosceptic governing parties.-Is Italy the new Greece?-

    Perhaps the clearest indicator of the rising fear about Italy: the yield on the country's benchmark 10-year government bond.

    Yields reflect the surety with which investors think they will get their money back, and tend to move in tandem with the stability of a country's economic and political situation. Government debt from big economies like the US and Japan usually have rock-bottom yields, under the assumption that they will never default.

    Italian bond yields have jumped more than 20% in just over a week, rising to almost 3.5%, the highest level since 2014. On Tuesday, the spread between yields on the Italian 10-year bond and that of the Greek 10-year was the lowest since 2009, during the depths of the financial crisis. Greece is largely seen as the least secure economy in the eurozone, and the fact that this gap is now so narrow is a troubling indicator for Italy.-Compare those yields to Germany, the eurozone's largest and most powerful economy-

    What's going on the Italian bond market is made even more clear when looking at a chart displaying the spread — the gap in yield — between Italy's 10-year bond and the 10-year German bund. On Tuesday, that gap climbed above 3%. Germany's 10-year trading at a roughly 0.4% yield.

    Germany's government debt is widely seen as being one of the safest investment vehicles on the planet, thanks to the countries staunch commitment to running a budget surplus. Italy, on the other hand, is looking increasingly unsafe to investors, sending bond yields soaring.
    See the rest of the story at Business Insider Reported by Business Insider 28 minutes ago.

    0 0

    The euro was lifted on Wednesday by reports that Italy plans to reduce its budget deficit over the next three years, but traders said the gains could be fleeting. Reported by Reuters 57 minutes ago.

    0 0

    Gluten Free Food Market By Products, By Distribution Channels, Regional Outlook (U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Netherlands, Denmark, China, India, Japan, South Korea, Thailand, Malaysia, Australia, Brazil, Argentina, Saudi Arabia, UAE, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

    Sellbyville, Delaware, Oct. 03, 2018 (GLOBE NEWSWIRE) --Global Gluten Free Food Market is projected to cross the revenue of USD 12.5 billion by 2024; according to a new research report by Global Market Insights, Inc. Growing consumer awareness regarding celiac problems, autoimmune problems and gluten allergy cases coupled with health issues which includes obesity and indigestion may drive the global market demand. Increasing number of hypermarkets and supermarkets in China, Germany, UK, and the U.S., which has upsurge awareness regarding these food products may propel product demand.

    It is a protein which is found in rye, barley, wheat and other related byproducts. Increasing food intolerances and allergies accompanied with rising consumer health concern should drive market demand. Growing incidences of celiac diseases in the U.S., Germany, UK, and France with stringent government mandates by FDA and EU Commission regarding labelling of nutritional products should drive the market demand.

    *Request for a sample of this research report @ *https://www.gminsights.com/request-sample/detail/226

    Gluten free food market size from cereals & snacks may surpass consumption at over 120 kilo tons by 2024. These are used in various cereals products which improves cholesterol levels, promotes digestive health and increases energy levels. These products are used in snacks as they avert sugar content, detox body and eliminates carbs and calories, thus increasing the product demand.

    Gluten free pizza & pasta market demand may register significant growth at over 8% up to 2024. These products are now replacing traditional pizza owing to several benefits which includes lowering of cholesterol, aid in gaining less weight, manage insulin levels and helps with skin ailments, thereby stimulating the global market growth.

    Browse key industry insights spread across 190 pages with 191 market data tables and 34 figures & charts from the report, *“Gluten Free Food Market” *in detail along with the table of contents:

    https://www.gminsights.com/industry-analysis/gluten-free-food-market

    Hospital & drug store for gluten free food market demand is likely to register growth at about 8.5% over the foreseeable timeframe. Several drug stores are offering gluten-free sections or departments pertaining to rising demand from coeliac patients along with adverse health risks, which may accelerate industry growth.

    The U.S. market demand may witness growth at about 9.5% over the forecast period. Growing food allergies and intolerances owing to wheat products in the dietary supplements may drive the regional product demand. Increasing celiac problems in the region along with regulations by FDA regarding health benefits may favor industry growth in the region.

     Italy market outlook is anticipated to surpass USD 820 million by 2024 due to increasing bakery products and pizza demand. Increase in working population along with hectic lifestyle has led to rise in pizza demand in the region. Rise in variety of products in the European supermarket mainly frozen pizza is mainly increasing product demand.

     Japan market demand should register significant gains at around 9% over the predicted timeframe. Consumers are keen on maintaining a healthy diet and health conditions related to metabolic syndrome have encouraged a substantial number of consumers to seek products with health benefits and nutritional value, thereby driving regional growth.

    CEREALTO, Wheafree, Glutafin, DI Manufacturing and Prima Foods are the key industrial players in the global market. New product launches, and strong R&D may enhance product portfolio, which in turn boost the industry growth. Most of the researchers are developing and focusing on novel applications of legume flour product to increase gluten free demand which in turn may accelerate gluten free food market over the forecast time-frame.

    *Make an inquiry for purchasing this report @* https://www.gminsights.com/inquiry-before-buying/226

    *Browse Related Reports:*

    · *Food Colorants Market Size 2018 – 2024*

    Global Food Colorants Market outlook was at over 60 kilo tons in 2017 and is anticipated to surpass USD 4.7 billion by 2024. Shifting preference towards colored products due to flavor perception will drive the global market growth.
    https://www.gminsights.com/industry-analysis/food-colorant-market

    · *U.S. Frozen Bakery Market Size 2018 – 2024*

    U.S. Frozen Bakery Market size was more than USD 6 billion in 2017 and will witness 4.3% CAGR during the forecast timespan, driven by the rising demand for ready to eat and convenience food market in the country.
    https://www.gminsights.com/industry-analysis/us-frozen-bakery-market

    *About Global Market Insights*

    Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

    CONTACT: Contact Us:
    Arun Hegde
    Corporate Sales, USA
    Global Market Insights, Inc.
    Phone: 1-302-846-7766
    Toll Free: 1-888-689-0688
    Email: sales@gminsights.com
    Web: https://www.gminsights.com
    Blog: http://l2food.com/ Reported by GlobeNewswire 56 minutes ago.

    0 0

    Research focused on supporting and validating Emerald’s intellectual property and development of its pipeline of proprietary cannabis products

    VICTORIA, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) has entered into a research agreement with VivaCell Biotechnologies Spain S.L.U. (“VivaCell”). VivaCell is an institute focused on cannabis research, which will provide its cannabis-industry-leading contract research organization (CRO) services to Emerald to elucidate the mechanism of action of proprietary formulations and dosage forms that Emerald is developing. This collaboration has the potential to strengthen Emerald’s intellectual property portfolio and assist in establishing Emerald as a leader in the development of proprietary cannabis products for medical-use and improved adult-use products with more precise and consistent delivery, dosage, and formulations.“There are a rare few organizations that focus their understanding of the cannabis plant at the heart of its scientific development and strategic operations. We’re fortunate to have VivaCell as part of the Emerald Health group of companies and look forward to working on this project,” said Chris Wagner, CEO of Emerald. “With 17 patents filed to date, we are advancing our product development process. The data from this work will aid us in this process. Our goal is to expand our product pipeline with innovative products substantiated by scientific data and protected by our intellectual property.”

    VivaCell was founded in 2003 as a spin-off of the AINP and Cannabis EU projects by a group of internationally renowned researchers. VivaCell’s in-house research and development capabilities are complemented through its partnerships with top academic research centers at the University of Córdoba, Complutense University of Madrid, Instituto Cajal in Madrid, and University of Piemonte Orientale (Italy). This model allows VivaCell to utilize a wide breadth of expertise in biomedicine, pharmacology and chemistry to optimize their contract research offerings to support the product development of their clients.

    “Emerald’s focus on scientific innovation has the potential to produce a future product pipeline of next-wave cannabis products that fit the needs and preferences of both adult-use consumers and patients,” said Mari-Luz Bellido, Managing Director of VivaCell. “We believe that cannabis has the potential to be developed into consistent, high-value downstream products. We are pleased to support the development of Emerald’s intellectual property by employing our deep cannabis research experience and conduct rigorous preclinical studies. ”

    VivaCell is a wholly-owned subsidiary of Emerald Health Sciences, which also owns approximately 32% of the issued and outstanding shares of Emerald Health Therapeutics, Inc. Accordingly, both VivaCell and EHS are related parties of the Company for purposes of National Instrument 61-01: Protection of Minority Security Holders in Special Transactions. The transaction is exempt from the valuation and minority approval requirements of NI 61-101 pursuant to the exemptions in Sections 5.5(b) and 5.7(1)(a) of NI 61-101.

    *About **VivaCell Biotechnologies Spain S.L.U.*

    VivaCell Biotechnologies España SL is a privately held research company focused on new non-psychotropic cannabinoids for the treatment of inflammatory and neurodegenerative diseases. It is a worldwide pioneer in the discovery and research of cannabidiol and cannabigerol chemical derivatives that improve the therapeutic properties of the natural cannabinoids. Additionally, VivaCell’s expertise includes research on hemp extracts (non-psychotropic cannabis varieties) such as CDE-001 to improve inflammatory skin conditions as atopic dermatitis. In addition, as a leading cannabis research institute, VivaCell provides broad contract research services that maintain exceptionally high standards for their scientific teams, and state-of-the-art facilities, with a focus on expediting research programs, drug discovery and lead candidate selection, and preclinical development. More information about the company is available *here*.

    *About Emerald Health Therapeutics, Inc.*

    Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC, and is in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and has secured a long-term supply contract for approximately 500 acres of industrial hemp in 2018 and up to 1000 acres in 2019 to 2022, which provides low-cost cannabidiol (CBD) supply for the company’s manufacturing needs.. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

    Please visit www.emeraldhealth.ca for more information or contact:
    Rob Hill, Chief Financial Officer
    (800) 757 3536 Ext. #5

    Ray Lagace, Investor Relations Manager
    (800) 757 3536 Ext. #5
    invest@emeraldhealth.ca

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined
    in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    Cautionary Note Regarding Forward-Looking Statements: Certain statements made in this press release that are not historical facts are forward-looking statements and are subject to important risks, uncertainties and assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements. Such statements include strengthening Emerald’s intellectual property portfolio; establishing Emerald as a leader in development of proprietary cannabis products; advancing Emerald’s product development process; expanding Emerald’s product pipeline with innovative products substantiated by scientific data and protected by intellectual property; and development of cannabis into consistent, high-value downstream products. .

    We cannot guarantee that any forward-looking statement will materialize, and readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements involve risks and uncertainties related to, among other things, failure to obtain regulatory approvals; failure to obtain necessary financing; results of scientific research; regulatory changes; demand for products; efficacy of products; as well as the risk factors described in the Company’s annual information form and other regulatory filings. The forward-looking statements contained in this press release represent our expectations as of the date hereof. Forward-looking statements are presented for the purpose of providing information about management's current expectations and plans and allowing investors and others to obtain a better understanding of our anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes. The Company undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law. Reported by GlobeNewswire 56 minutes ago.

    0 0

    Global shares were mixed Wednesday after reports suggested Italy will rein in spending after 2019, following heavy criticism of its budget plan. Reported by Newsday 1 hour ago.

    0 0

    Italy's populist government will cut its budget deficit targets from 2020, Economy Minister Giovanni Tria said on Wednesday, after investors sold off Italian assets and European Union ministers criticised its plans to jack up spending next year. Reported by Reuters India 31 minutes ago.

    0 0

    The euro was lifted today by reports that Italy plans to reduce its budget deficit over the next three years, but traders said the gains could be fleeting. Reported by RTE.ie 38 minutes ago.

    0 0

    Indian shares tumbled on Wednesday, with selling accelerating in late trade as the rupee continued to weaken, oil prices held near four-year highs and turmoil in Italy soured investors' risk appetite. Reported by RTTNews 29 minutes ago.

older | 1 | .... | 1028 | 1029 | (Page 1030) | 1031 | 1032 | .... | 1077 | newer